Skip to main content

LOS ANGELES CAPITAL MANAGEMENT LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1177206 LOS ANGELES, CA

Position in NBIX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$19,643,883
-$163,498,075 QoQ
Shares Held
149,111
-88.5% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 49.83066306308723.ToString("F0")% Shared 0.ToString("F0")% None 50.16933693691277.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $63,936,746 across 33 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (30.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
149,111 $19,643,883

All Filings in NBIX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $19,643,883 149,111
2025-12-31 $183,141,958 1,291,278
2025-09-30 $168,842,887 1,202,756
2025-06-30 $93,595,058 744,650
2025-03-31 $421,164 3,808
2024-12-31 $69,999,930 512,820
2024-09-30 $48,478,584 420,748
2024-06-30 $7,831,357 56,885
2024-03-31 $33,842,947 245,381
2023-12-31 $121,007,198 918,391
2023-09-30 $62,258,062 553,405
2023-06-30 $51,921,391 550,598
2023-03-31 $64,259,010 634,845
2022-12-31 $91,215,372 763,692
2022-09-30 $84,114,708 791,966
2021-09-30 $1,344,274 14,016
2021-06-30 $1,867,862 19,193
2021-03-31 $5,392,318 55,448
2020-12-31 $13,959,306 145,637
2020-09-30 $16,996,953 176,757
2020-06-30 $16,241,372 133,126
2020-03-31 $925,652 10,695